Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 54Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Neoplasm Metastasis 4Sarcoma, Ewing 3Neoplasms 3Medulloblastoma 3Lymphoma, Non-Hodgkin 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Wilms Tumor 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Lymphoma 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioblastoma 2Ependymoma 2Colonic Neoplasms 2Xanthogranuloma, Juvenile 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Teratoma 1Recurrent Squamous Cell Lung Carcinoma 1

Interventions

Taxes 2Standard of Care 2Practice Guidelines as Topic 2Paclitaxel 2palbociclib 1nilotinib 1Telemedicine 1Rifaximin 1Radiation Dose Hypofractionation 1Letrozole 1Interviews as Topic 1Hydroxychloroquine 1Early Intervention, Educational 1Docetaxel 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anatomic Stage I Breast Cancer AJCC v8 × palbociclib × Clear all
NCT03774472 2025-02-17

Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
15 enrolled 11 charts
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡